Tumor-Specific Clonotype, Metabolic Profile, and PET/CT in Predicting Chemotherapy Response in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Clinical trial NCT02405078 · COMPLETED
Trial details
- NCT number
- NCT02405078
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-13
- Primary completion
- 2022-10-03
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.